Skip to main content

Table 2 Median AUC of the symptom scores, medication scores and combined SMS for the 21 day observation period during main birch pollen exposure in each of the two seasons

From: Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

 

rBet v 1-FV

Comparator

Wilcoxon–Mann–Whitney U-Test

 

median (IQR)

median (IQR)

p-values

First treatment year

   

Symptom score

3.10 (9.36)

5.69 (4.71)

0.400

Medication score

1.43 (3.10)

2.83 (5.75)

0.285

SMS

5.86 (14.02)

12.40 (9.32)

0.330

Second treatment year

   

Symptom score

2.81 (4.02)

1.67 (2.41)

0.393

Medication score

0.29 (1.36)

1.05 (3.50)

0.730

SMS

3.00 (6.50)

2.93 (4.86)

0.812